Global Urinary Stone Treatment Devices and Equipment Markets 2020: Focus on Extracorporeal Shock Wave Lithotripsy, Holmium Laser, Intracorporeal Lithotripsy, Stone Retrieval Ureteral Stents -

DUBLIN--()--The "Urinary Stone Treatment Devices And Equipment Global Market Report 2020" report has been added to's offering.

The global urinary stone treatment devices and equipment market was valued at about $0.6 billion in 2018 and is expected to grow to $0.74 billion at a CAGR of 5.4% through 2022.

The urinary stone treatment devices (or) equipment market consists of sales of urinary stone treatment devices and related services which are used in the treatment and management of stones formed in the kidneys and urinary tract. Stones are made of minerals in the urine that form crystals and grow into stones. About 85% of the stones are made of calcium, and the remaining portion composed of various substances including cysteine, uric acid or struvite.

In 2018, North America was the largest region in the urinary stone treatment devices and equipment market. During the forecast period, Asia Pacific is expected to register the highest growth rate.

The increasing prevalence of Kidney Stones, specially in the geriatric population is driving the urinary stone treatment devices and equipment market growth. The incidence of urolithiasis is reported to be increasing across the globe. According to a study, about 30% people around the world are obese and nearly 900 million people are geriatrics which is expected to increase to 1.4 billion by 2030. The incidence of kidney stones is globally increasing with an estimated prevalence ranging up to 15%. According to a Robotic Stone survey in 2017, the probability of stone formation in Saudi Arabia is 20.1% and 13% in the USA. Stone diseases or urolithiasis are frequent in aging population. Asia Pacific is presently home to more than half of the world's aging population above 60 years and the number is expected to rise to 2.45 billion by 2050.

Lack of public awareness and proper knowledge about the problems associated with urinary stone diseases, particularly in the under-developed countries acts as a major factor hindering the market growth. This lack of proper knowledge becomes a roadblock for the Urinary stone treatment device manufacturers because of many cases being unnoticed/unaddressed which amount to decrease in demand for these devices. For instance, according to a study conducted in Saudi Arabia, 44% of the participants had a family member suffering from urinary stone disease and 9.6% had urinary stones themselves, which suggests high prevalence of the ailment in the country. But there was an incidence of lack of awareness and misconceptions among the people in most parts of that region.

Companies in the industry are investing in advanced laser technology and robot assisted surgeries to treat urolithiasis. Urolithiasis is a disease condition where calculi or stones are formed in the kidney, bladder, and urinary tract of the human body. Urolithiasis open surgeries are increasingly conducted with the help of minimally invasive procedures, advanced lasers, enhanced surgical tools and robot-assisted devices to reduce hospitalization time, less invasive and enable a shorter bladder catheterization time. For instance, Boston Scientific Co. is investing by way of an agreement with Lumenis, a company offering minimally-invasive clinical solutions, and holmium laser technology, to use and leverage the benefits of advanced laser technology.

In March 2019, with reference to a field corrective action sent by Medicines and Healthcare products Regulatory Agency (MRHA), a regulatory body for medical devices of the UK, C.R Bard, a subsidiary of Becton, Dickinson and Company (BD) removed its Women's Pelvic Organ Prolapse and Stress Urinary Incontinence Mesh devices from the European market.

This initiative of ceasing production and distribution of these devices and a removal of these products from hospitals and distribution centers was done in order to protect patient and user safety from these devices. Similarly in August 2018, ConvaTec, recalled its specific suction catheters, gastroenteral tubes, intermittent urology catheters and sterile urine drainage bags in order to avoid patient risk of developing infection.

Major players in the market are Boston Scientific, Cook Medical, C.R. Bard, DirexGroup, Dornier MedTech.


  • Markets Covered: 1) By Products: Extracorporeal Shock Wave Lithotripsy Devices, Holmium Laser Devices, Intracorporeal Lithotripsy Devices, Stone Retrieval Devices, Ureteral Stents 2) By End Users: Hospitals, Clinics, Ambulatory Surgical Centers
  • Companies Mentioned: Boston Scientific, Cook Medical, C.R. Bard, DirexGroup, Dornier MedTech
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Other Companies Mentioned

  • Bard Medical Division
  • Richard Wolf
  • Siemens Healthineers AG
  • Olympus Corporation
  • Karl Storz
  • HealthTronics Inc.
  • Lumenis Ltd.
  • Storz Medical
  • Medispec Ltd.
  • Coloplast
  • Allengers Medical Systems Ltd.
  • Conmed Corporation
  • Guangzhou Potent Optotronic Technology Co. Ltd.
  • Becton Dickinson and Company
  • Medtronic plc
  • American Medical Systems
  • Limmer Laser GmbH
  • GEMSS Co. Ltd.
  • Convergent Laser Technologies
  • Hobbs Medical Inc
  • Endo Health Solutions Inc.
  • Medical Coaches Inc
  • Applied Medical Technology Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900